German China
Rigenerand commences 3D bioreactor development for cGMP extracellular vesicle exosomes (EV) production (Public Domain)
Italy: Production of 3D Bioreactor

Rigenerand to Contribute EV cGMP Technologies to European Project Consortium

Italian biotech company Rigenerand has commenced development of a novel 3D bioreactor and pipeline, specifically designed for the incremental production of extracellular vesicles exosomes (EVs) in a cGMP environment. The company’s project development will be supported with part of a grant of $ 5 million from Horizon 2020 for the H2020-EU.1.2.2.-FET Proactive program, awarded to the Biogenic Organotropic Wetsuits project. This project comprises a consortium of companies involving Rigenerand.

Read on
Particles of the H1N1 influenza virus. (Helmholtz Centre for Infection Research (HZI))
Germany: Immunology

Crucial Role of Receptor in Defensive Response to Influenza

When influenza viruses enter our body, the immune system recognises them as being foreign by means of various receptors and starts a defence programme.Scientists of the Helmholtz Centre for Infection Research (HZI) in Braunschweig and of the Otto von Guericke University Magdeburg recently studied the detailed role of a certain receptor in this first line of defence. They discovered that the receptor activates natural killer cells, which use messenger substances to activate other immune cells and then eliminate body cells that are infected by viruses.

Read on
Fig. 1: The bacterial target cells are purified and separated from the sample matrix in a microfluidic disposable cartridge by means of a magnetic field (cutout). (rqmicro)
Flow Cytometry

Quantifying Legionella in Shorter Time

Identifying the source of infection is essential for taking action in outbreaks of Legionnaire's disease. The combination of immunomagnetic separation and flow cytometry delivers precise results in less than two hours and knows virtually no limits to the variety of applications.

Read on